Anson Capital Inc. Sells 17,230 Shares of Medical Properties Trust, Inc. (NYSE:MPW)

Anson Capital Inc. trimmed its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 59.6% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,693 shares of the real estate investment trust’s stock after selling 17,230 shares during the period. Anson Capital Inc.’s holdings in Medical Properties Trust were worth $68,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of MPW. DekaBank Deutsche Girozentrale increased its holdings in shares of Medical Properties Trust by 5.8% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 143,910 shares of the real estate investment trust’s stock valued at $863,000 after acquiring an additional 7,874 shares during the last quarter. MCF Advisors LLC acquired a new position in Medical Properties Trust during the third quarter valued at approximately $230,000. Mirae Asset Global Investments Co. Ltd. grew its holdings in Medical Properties Trust by 34.9% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,342 shares of the real estate investment trust’s stock valued at $139,000 after purchasing an additional 6,037 shares during the last quarter. International Assets Investment Management LLC raised its position in shares of Medical Properties Trust by 378.4% in the third quarter. International Assets Investment Management LLC now owns 885,983 shares of the real estate investment trust’s stock valued at $5,183,000 after purchasing an additional 700,783 shares during the period. Finally, Lecap Asset Management Ltd. lifted its stake in shares of Medical Properties Trust by 150.9% in the third quarter. Lecap Asset Management Ltd. now owns 276,317 shares of the real estate investment trust’s stock worth $1,616,000 after buying an additional 166,182 shares during the last quarter. Institutional investors and hedge funds own 71.79% of the company’s stock.

Medical Properties Trust Stock Performance

Shares of NYSE:MPW traded down $0.31 during trading on Friday, hitting $4.62. 9,984,086 shares of the stock were exchanged, compared to its average volume of 17,212,068. The company has a market capitalization of $2.77 billion, a price-to-earnings ratio of -1.72, a price-to-earnings-growth ratio of 0.69 and a beta of 1.29. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93. Medical Properties Trust, Inc. has a 1-year low of $2.92 and a 1-year high of $6.55. The company’s fifty day simple moving average is $5.15 and its 200-day simple moving average is $4.91.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.75). The business had revenue of $266.60 million for the quarter, compared to analysts’ expectations of $259.53 million. During the same quarter in the prior year, the company earned $0.48 EPS. Medical Properties Trust’s quarterly revenue was down 21.0% on a year-over-year basis. Sell-side analysts expect that Medical Properties Trust, Inc. will post 0.85 EPS for the current fiscal year.

Medical Properties Trust Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, October 10th. Shareholders of record on Monday, September 9th were given a $0.08 dividend. The ex-dividend date was Monday, September 9th. This represents a $0.32 dividend on an annualized basis and a yield of 6.93%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -11.90%.

Insiders Place Their Bets

In other news, Director Elizabeth N. Pitman bought 8,087 shares of the business’s stock in a transaction dated Wednesday, September 18th. The stock was bought at an average price of $6.01 per share, for a total transaction of $48,602.87. Following the completion of the purchase, the director now owns 76,740 shares of the company’s stock, valued at approximately $461,207.40. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Elizabeth N. Pitman purchased 8,087 shares of Medical Properties Trust stock in a transaction that occurred on Wednesday, September 18th. The shares were acquired at an average price of $6.01 per share, for a total transaction of $48,602.87. Following the transaction, the director now directly owns 76,740 shares in the company, valued at approximately $461,207.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total transaction of $89,921.40. Following the completion of the sale, the director now directly owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 63,335 shares of company stock valued at $318,825. 1.53% of the stock is currently owned by insiders.

Analysts Set New Price Targets

MPW has been the topic of a number of research analyst reports. Truist Financial raised their target price on shares of Medical Properties Trust from $5.00 to $6.00 and gave the company a “hold” rating in a research note on Friday, September 13th. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price objective on the stock in a research note on Friday, September 13th. Wolfe Research upgraded Medical Properties Trust to a “hold” rating in a research note on Monday, September 23rd. Finally, BNP Paribas downgraded Medical Properties Trust from an “outperform” rating to a “neutral” rating and dropped their price target for the stock from $6.00 to $4.00 in a research report on Tuesday, July 2nd. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Medical Properties Trust currently has a consensus rating of “Hold” and a consensus target price of $5.38.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.